ATX-F8-117 (Apitope Technology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameATX-F8-117 (Apitope Technology)
Drug Alias NameiATX Factor VIIIiATX-FVIIIATX-F8 program (Apitope Technology)API F-VIIIATX-UV2 +[10] 
ClassificationBiologics
Mechanisms of ActionThyroid stimulating hormone receptor agonists
TargetsThyroid stimulating hormone receptor
Therapy Area/IndicationsAutoimmune DiseasesHemophilia AGraves Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAntitopeApitope Technology
China Registration ClassN/A

Develop Information

Active CompaniesApitope TechnologyAntitope
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesHemophilia AGraves Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A